Abstract:Isacsson and Adler (1) noted that the Hamilton Depression Rating Scale (HDRS) has limited reliability in assessing low levels of depression. The authors draw two conclusions on this assumption: (i) The precision of ratings decreases as the patient improves and (ii) improvements starting at lower levels of depression will be systematically underestimated compared with improvements starting at higher levels of depression severity. It is not a novel fact that the HDRS is an imperfect measure of depression severity. As the HDRS is considered to be the gold standard for the assessment of depression severity, it is, nevertheless, important to underline the deficits in its reliability; thus, I agree with the authors call for better instruments to assess the severity of depression. Where I got lost, however, is how these methodological restrictions of the HDRS lead to the authors conclusion that randomized controlled clinical trials (RCTs) underestimate the efficacy of antidepressants in less severe depression? The results only highlight that the reliability decreases with decreasing levels of depression severity. This could mean both that RCTs underestimate or overestimate the efficacy of antidepressant drugs in less severe depression. Similarly, the fact that improvements starting at lower levels of depression will be less reliable than improvements starting at higher levels simply indicates that we do have a measurement problem in RCTs using the HDRS to assess subthreshold to mild depression [NICE nomenclature of HDRS cut-off scores (2)] respectively mild to moderate depression [American Psychiatric Association (APA) nomenclature (2)]. As both patient groups (verum and placebo) have low levels of depression at baseline and both patient groups might improve over time, the measurement bias tells us nothing about whether the effects of antidepressant drugs are underestimated or overestimated or whether trials using the HDRS for the assessment of lower levels of depression are just faced with a large variance of results because of the measurement bias. Thus, the only finding of the article by Isacsson and Adler (1) is that the HDRS is a rather imperfect gold standard for the assessment of depression severity. How comes that the authors conclude that the efficacy of antidepressants is underestimated? There are three possible explanations I can think of: (i) A lack of statistical competency leading to the misinterpretation of results. However, this seems rather unlikely, as the article is on a high methodological level; (ii) the authors believe in the efficacy of antidepressant drugs and therefore tend to interpret results in favor of their beliefs. Beliefs prior to a study are known to have an impact on posterior interpretations of the findings (3); (iii) M. Adler stated that he has received...fees for speaking from Eli Lilly, Bristol Meyers Squibb, Sanofi-Aventis and for speaking and preparing manuscripts from AstraZeneca, which, too, could explain the unsound interpretation of results in favor of antidepressant drugs. To date, there is no evidence that antidepressant drugs are significantly superior to placebo in patients with subthreshold to mild depression (= APA mild to moderate depression) (4, 5). Consequently, antidepressant drugs should not routinely be used as first-line treatment for (persistent) subthreshold depressive symptoms or mild depression because of the poor risk–benefit ratio (4, 5). Forthcoming RCTs on antidepressant drug treatments based on psychometrically better assessment instruments might change this recommendation, while the study of Isacsson and Adler (1) is inappropriate to do so, despite its full-bodied title.

Mussel-inspired multifunctional supramolecular hydrogels with self-healing, shape memory and adhesive properties

Mussel-inspired Tough Hydrogels with Self-Repairing and Tissue Adhesion

Dynamic Crosslinked Injectable Mussel-Inspired Hydrogels with Adhesive, Self-Healing, and Biodegradation Properties

Preparation and characterization of mussel-inspired hydrogels based on methacrylated catechol-chitosan and dopamine methacrylamide

Chitosan‐based Double Network Hydrogels with Self‐healing and Dual‐responsive Shape Memory Abilities

Tough, self-healable and tissue-adhesive hydrogel with tunable multifunctionality

Mussel-inspired biocompatible polydopamine/carboxymethyl cellulose/polyacrylic acid adhesive hydrogels with UV-shielding capacity

On-demand and negative-thermo-swelling tissue adhesive based on highly branched ambivalent PEG-catechol copolymers.

The Multifaceted Nature of Catechol Chemistry: Bioinspired Ph-Initiated Hyaluronic Acid Hydrogels with Tunable Cohesive and Adhesive Properties

Development of the mussel-inspired pH-responsive hydrogel based on Bletilla striata polysaccharide with enhanced adhesiveness and antioxidant properties

Constructing High Performance Hydrogels with Strong Underwater Adhesion through a “Mussel Feet-Rock” Inspired Strategy

Ultrastretchable, Self-Adhesive, Strain-Sensitive and Self-Healing GO@DA/Alginate/P(AAc-co-AAm) Multifunctional Hydrogels Via Mussel-Inspired Chemistry

Mussel-inspired hyperbranched poly(amino ester) polymer as strong wet tissue adhesive.

Tannic Acid-Based Multifunctional Hydrogels with Facile Adjustable Adhesion and Cohesion Contributed by Polyphenol Supramolecular Chemistry

THE PATHOLOGY OF SPONTANEOUS AND INDUCED SUBCUTANEOUS NODULES IN RHEUMATIC FEVER.

Mussel-Inspired Multifunctional Hydrogels with Adhesive, Self-Healing, Antioxidative, and Antibacterial Activity for Wound Healing.

Unsound interpretation of findings on a measurement bias in antidepressant drug research

Bioinspired Injectable Self-Healing Hydrogel Sealant with Fault-Tolerant and Repeated Thermo-Responsive Adhesion for Sutureless Post-Wound-Closure and Wound Healing

A pH, glucose, and dopamine triple-responsive, self-healable adhesive hydrogel formed by phenylborate–catechol complexation

Mussel-Inspired Conductive Hydrogel with Self-Healing, Adhesive, and Antibacterial Properties for Wearable Monitoring

Sparse, random array processing for space-based radar